Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex Article Swipe
Qi Hao
,
Manoj K Rathinaswamy
,
Kelly L. Klinge
,
Matthew Bratkowski
,
Amirhossein Mafi
,
Christina K. Baumgartner
,
Keith M. Hamel
,
Gesine K. Veits
,
Rinku Jain
,
Claudio Catalano
,
Mark E. Fitzgerald
,
Alexander W. Hird
,
Eunice Park
,
Harit U. Vora
,
James A. Henderson
,
Kenton L. Longenecker
,
Charles W. Hutchins
,
Wei Qiu
,
Giovanna Scapin
,
Qi Sun
,
Vincent S. Stoll
,
Chaohong Sun
,
Ping Li
,
Dan Eaton
,
David Stokoe
,
Stewart L. Fisher
,
Christopher G. Nasveschuk
,
Marcia N. Paddock
,
Michael E. Kort
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1038/s42004-024-01263-7
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1038/s42004-024-01263-7
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s42004-024-01263-7
- OA Status
- gold
- Cited By
- 4
- References
- 58
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4401650234
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4401650234Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s42004-024-01263-7Digital Object Identifier
- Title
-
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-08-16Full publication date if available
- Authors
-
Qi Hao, Manoj K Rathinaswamy, Kelly L. Klinge, Matthew Bratkowski, Amirhossein Mafi, Christina K. Baumgartner, Keith M. Hamel, Gesine K. Veits, Rinku Jain, Claudio Catalano, Mark E. Fitzgerald, Alexander W. Hird, Eunice Park, Harit U. Vora, James A. Henderson, Kenton L. Longenecker, Charles W. Hutchins, Wei Qiu, Giovanna Scapin, Qi Sun, Vincent S. Stoll, Chaohong Sun, Ping Li, Dan Eaton, David Stokoe, Stewart L. Fisher, Christopher G. Nasveschuk, Marcia N. Paddock, Michael E. KortList of authors in order
- Landing page
-
https://doi.org/10.1038/s42004-024-01263-7Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1038/s42004-024-01263-7Direct OA link when available
- Concepts
-
Computational biology, Ternary complex, Protein tyrosine phosphatase, Biology, Ubiquitin ligase, Chemistry, Cell biology, Ubiquitin, Biochemistry, Receptor, Gene, EnzymeTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4Per-year citation counts (last 5 years)
- References (count)
-
58Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4401650234 |
|---|---|
| doi | https://doi.org/10.1038/s42004-024-01263-7 |
| ids.doi | https://doi.org/10.1038/s42004-024-01263-7 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39152201 |
| ids.openalex | https://openalex.org/W4401650234 |
| fwci | 1.9209889 |
| type | article |
| title | Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex |
| biblio.issue | 1 |
| biblio.volume | 7 |
| biblio.last_page | 183 |
| biblio.first_page | 183 |
| topics[0].id | https://openalex.org/T12104 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Protein Tyrosine Phosphatases |
| topics[1].id | https://openalex.org/T11041 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9991999864578247 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Ubiquitin and proteasome pathways |
| topics[2].id | https://openalex.org/T11482 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9984999895095825 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | RNA modifications and cancer |
| is_xpac | False |
| apc_list.value | 2680 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2890 |
| apc_paid.value | 2680 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2890 |
| concepts[0].id | https://openalex.org/C70721500 |
| concepts[0].level | 1 |
| concepts[0].score | 0.5794761776924133 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[0].display_name | Computational biology |
| concepts[1].id | https://openalex.org/C86756495 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5696399211883545 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7702931 |
| concepts[1].display_name | Ternary complex |
| concepts[2].id | https://openalex.org/C85528070 |
| concepts[2].level | 3 |
| concepts[2].score | 0.4903876781463623 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q643602 |
| concepts[2].display_name | Protein tyrosine phosphatase |
| concepts[3].id | https://openalex.org/C86803240 |
| concepts[3].level | 0 |
| concepts[3].score | 0.42547935247421265 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[3].display_name | Biology |
| concepts[4].id | https://openalex.org/C134459356 |
| concepts[4].level | 4 |
| concepts[4].score | 0.41612592339515686 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q4274835 |
| concepts[4].display_name | Ubiquitin ligase |
| concepts[5].id | https://openalex.org/C185592680 |
| concepts[5].level | 0 |
| concepts[5].score | 0.3634132146835327 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[5].display_name | Chemistry |
| concepts[6].id | https://openalex.org/C95444343 |
| concepts[6].level | 1 |
| concepts[6].score | 0.33166998624801636 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[6].display_name | Cell biology |
| concepts[7].id | https://openalex.org/C25602115 |
| concepts[7].level | 3 |
| concepts[7].score | 0.32680225372314453 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q407111 |
| concepts[7].display_name | Ubiquitin |
| concepts[8].id | https://openalex.org/C55493867 |
| concepts[8].level | 1 |
| concepts[8].score | 0.2759631872177124 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[8].display_name | Biochemistry |
| concepts[9].id | https://openalex.org/C170493617 |
| concepts[9].level | 2 |
| concepts[9].score | 0.25613710284233093 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[9].display_name | Receptor |
| concepts[10].id | https://openalex.org/C104317684 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[10].display_name | Gene |
| concepts[11].id | https://openalex.org/C181199279 |
| concepts[11].level | 2 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[11].display_name | Enzyme |
| keywords[0].id | https://openalex.org/keywords/computational-biology |
| keywords[0].score | 0.5794761776924133 |
| keywords[0].display_name | Computational biology |
| keywords[1].id | https://openalex.org/keywords/ternary-complex |
| keywords[1].score | 0.5696399211883545 |
| keywords[1].display_name | Ternary complex |
| keywords[2].id | https://openalex.org/keywords/protein-tyrosine-phosphatase |
| keywords[2].score | 0.4903876781463623 |
| keywords[2].display_name | Protein tyrosine phosphatase |
| keywords[3].id | https://openalex.org/keywords/biology |
| keywords[3].score | 0.42547935247421265 |
| keywords[3].display_name | Biology |
| keywords[4].id | https://openalex.org/keywords/ubiquitin-ligase |
| keywords[4].score | 0.41612592339515686 |
| keywords[4].display_name | Ubiquitin ligase |
| keywords[5].id | https://openalex.org/keywords/chemistry |
| keywords[5].score | 0.3634132146835327 |
| keywords[5].display_name | Chemistry |
| keywords[6].id | https://openalex.org/keywords/cell-biology |
| keywords[6].score | 0.33166998624801636 |
| keywords[6].display_name | Cell biology |
| keywords[7].id | https://openalex.org/keywords/ubiquitin |
| keywords[7].score | 0.32680225372314453 |
| keywords[7].display_name | Ubiquitin |
| keywords[8].id | https://openalex.org/keywords/biochemistry |
| keywords[8].score | 0.2759631872177124 |
| keywords[8].display_name | Biochemistry |
| keywords[9].id | https://openalex.org/keywords/receptor |
| keywords[9].score | 0.25613710284233093 |
| keywords[9].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1038/s42004-024-01263-7 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210191625 |
| locations[0].source.issn | 2399-3669 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2399-3669 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Communications Chemistry |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Communications Chemistry |
| locations[0].landing_page_url | https://doi.org/10.1038/s42004-024-01263-7 |
| locations[1].id | pmid:39152201 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Communications chemistry |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39152201 |
| locations[2].id | pmh:oai:doaj.org/article:1f2680b79836478cba894b08e1a585a6 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Communications Chemistry, Vol 7, Iss 1, Pp 1-16 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/1f2680b79836478cba894b08e1a585a6 |
| locations[3].id | pmh:oai:osti.gov:2470199 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306402487 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) |
| locations[3].source.host_organization | https://openalex.org/I139351228 |
| locations[3].source.host_organization_name | Office of Scientific and Technical Information |
| locations[3].source.host_organization_lineage | https://openalex.org/I139351228 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.osti.gov/biblio/2470199 |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:11329783 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Commun Chem |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11329783 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5063919203 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6246-2153 |
| authorships[0].author.display_name | Qi Hao |
| authorships[0].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Qi Hao |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[1].author.id | https://openalex.org/A5102720175 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5909-4353 |
| authorships[1].author.display_name | Manoj K Rathinaswamy |
| authorships[1].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Manoj K. Rathinaswamy |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[2].author.id | https://openalex.org/A5025787573 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Kelly L. Klinge |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[2].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[2].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[2].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | AbbVie (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kelly L. Klinge |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[3].author.id | https://openalex.org/A5028166846 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-3911-0533 |
| authorships[3].author.display_name | Matthew Bratkowski |
| authorships[3].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Matthew Bratkowski |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[4].author.id | https://openalex.org/A5014998024 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8366-6785 |
| authorships[4].author.display_name | Amirhossein Mafi |
| authorships[4].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Amirhossein Mafi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[5].author.id | https://openalex.org/A5105880499 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6872-6209 |
| authorships[5].author.display_name | Christina K. Baumgartner |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[5].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[5].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[5].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | AbbVie (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Christina K. Baumgartner |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[6].author.id | https://openalex.org/A5063212732 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1559-8431 |
| authorships[6].author.display_name | Keith M. Hamel |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[6].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[6].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[6].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | AbbVie (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Keith M. Hamel |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[7].author.id | https://openalex.org/A5033912160 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Gesine K. Veits |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[7].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[7].institutions[0].ror | https://ror.org/05334he48 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Gesine K. Veits |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[8].author.id | https://openalex.org/A5102981919 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-2285-7809 |
| authorships[8].author.display_name | Rinku Jain |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[8].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[8].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[8].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | AbbVie (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Rinku Jain |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[9].author.id | https://openalex.org/A5066092735 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2437-6235 |
| authorships[9].author.display_name | Claudio Catalano |
| authorships[9].affiliations[0].raw_affiliation_string | Nanoimaging, 4-C Gill Street, Woburn, MA, 01801, USA |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Claudio Catalano |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Nanoimaging, 4-C Gill Street, Woburn, MA, 01801, USA |
| authorships[10].author.id | https://openalex.org/A5014370378 |
| authorships[10].author.orcid | https://orcid.org/0009-0001-9449-7892 |
| authorships[10].author.display_name | Mark E. Fitzgerald |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[10].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[10].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[10].institutions[0].ror | https://ror.org/05334he48 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Mark Fitzgerald |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[11].author.id | https://openalex.org/A5106567690 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Alexander W. Hird |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[11].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[11].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[11].institutions[0].ror | https://ror.org/05334he48 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Alexander W. Hird |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[12].author.id | https://openalex.org/A5003289552 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-1159-2374 |
| authorships[12].author.display_name | Eunice Park |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[12].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[12].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[12].institutions[0].ror | https://ror.org/05334he48 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Eunice Park |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[13].author.id | https://openalex.org/A5091087121 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Harit U. Vora |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[13].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[13].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[13].institutions[0].ror | https://ror.org/05334he48 |
| authorships[13].institutions[0].type | company |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Harit U. Vora |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[14].author.id | https://openalex.org/A5026655461 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-6278-9973 |
| authorships[14].author.display_name | James A. Henderson |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[14].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[14].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[14].institutions[0].ror | https://ror.org/05334he48 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | James A. Henderson |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[15].author.id | https://openalex.org/A5078721849 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Kenton L. Longenecker |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[15].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[15].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[15].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | AbbVie (United States) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Kenton Longenecker |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[16].author.id | https://openalex.org/A5113723833 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Charles W. Hutchins |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[16].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[16].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[16].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | AbbVie (United States) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Charles W. Hutchins |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[17].author.id | https://openalex.org/A5040295474 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-5548-5629 |
| authorships[17].author.display_name | Wei Qiu |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[17].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[17].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[17].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | AbbVie (United States) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Wei Qiu |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[18].author.id | https://openalex.org/A5055675220 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-0724-2286 |
| authorships[18].author.display_name | Giovanna Scapin |
| authorships[18].affiliations[0].raw_affiliation_string | Nanoimaging, 4-C Gill Street, Woburn, MA, 01801, USA |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Giovanna Scapin |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Nanoimaging, 4-C Gill Street, Woburn, MA, 01801, USA |
| authorships[19].author.id | https://openalex.org/A5100427513 |
| authorships[19].author.orcid | https://orcid.org/0009-0003-5107-1909 |
| authorships[19].author.display_name | Qi Sun |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[19].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[19].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[19].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | AbbVie (United States) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Qi Sun |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[20].author.id | https://openalex.org/A5038597530 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | Vincent S. Stoll |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[20].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[20].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[20].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[20].institutions[0].type | company |
| authorships[20].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | AbbVie (United States) |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Vincent S. Stoll |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[21].author.id | https://openalex.org/A5003698505 |
| authorships[21].author.orcid | https://orcid.org/0000-0003-2314-3197 |
| authorships[21].author.display_name | Chaohong Sun |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[21].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[21].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[21].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[21].institutions[0].type | company |
| authorships[21].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | AbbVie (United States) |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Chaohong Sun |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[22].author.id | https://openalex.org/A5100435506 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-3314-943X |
| authorships[22].author.display_name | Ping Li |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[22].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[22].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[22].institutions[0].ror | https://ror.org/05334he48 |
| authorships[22].institutions[0].type | company |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Ping Li |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[23].author.id | https://openalex.org/A5074713940 |
| authorships[23].author.orcid | https://orcid.org/0000-0003-3933-0958 |
| authorships[23].author.display_name | Dan Eaton |
| authorships[23].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Dan Eaton |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[24].author.id | https://openalex.org/A5082108617 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-6333-5364 |
| authorships[24].author.display_name | David Stokoe |
| authorships[24].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | David Stokoe |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[25].author.id | https://openalex.org/A5046974786 |
| authorships[25].author.orcid | https://orcid.org/0009-0005-5167-5213 |
| authorships[25].author.display_name | Stewart L. Fisher |
| authorships[25].countries | US |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[25].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[25].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[25].institutions[0].ror | https://ror.org/05334he48 |
| authorships[25].institutions[0].type | company |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[25].institutions[0].country_code | US |
| authorships[25].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Stewart L. Fisher |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[26].author.id | https://openalex.org/A5017553294 |
| authorships[26].author.orcid | https://orcid.org/0000-0003-4671-6939 |
| authorships[26].author.display_name | Christopher G. Nasveschuk |
| authorships[26].countries | US |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I4210153832 |
| authorships[26].affiliations[0].raw_affiliation_string | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[26].institutions[0].id | https://openalex.org/I4210153832 |
| authorships[26].institutions[0].ror | https://ror.org/05334he48 |
| authorships[26].institutions[0].type | company |
| authorships[26].institutions[0].lineage | https://openalex.org/I4210153832 |
| authorships[26].institutions[0].country_code | US |
| authorships[26].institutions[0].display_name | C4 Therapeutics (United States) |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Christopher G. Nasveschuk |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | C4 Therapeutics Inc., 490 Arsenal Way, Watertown, MA, 02472, USA |
| authorships[27].author.id | https://openalex.org/A5025042492 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-8350-1593 |
| authorships[27].author.display_name | Marcia N. Paddock |
| authorships[27].affiliations[0].raw_affiliation_string | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Marcia Paddock |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Calico Life Sciences LLC, South San Francisco, CA, 94080, USA |
| authorships[28].author.id | https://openalex.org/A5089248430 |
| authorships[28].author.orcid | https://orcid.org/0000-0003-3059-9790 |
| authorships[28].author.display_name | Michael E. Kort |
| authorships[28].countries | US |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I2948539688 |
| authorships[28].affiliations[0].raw_affiliation_string | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| authorships[28].institutions[0].id | https://openalex.org/I2948539688 |
| authorships[28].institutions[0].ror | https://ror.org/02g5p4n58 |
| authorships[28].institutions[0].type | company |
| authorships[28].institutions[0].lineage | https://openalex.org/I2948539688 |
| authorships[28].institutions[0].country_code | US |
| authorships[28].institutions[0].display_name | AbbVie (United States) |
| authorships[28].author_position | last |
| authorships[28].raw_author_name | Michael E. Kort |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | AbbVie, 1 North Waukegan Rd, North Chicago, IL, 60064, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1038/s42004-024-01263-7 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12104 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Protein Tyrosine Phosphatases |
| related_works | https://openalex.org/W1970861248, https://openalex.org/W2102368462, https://openalex.org/W2054919679, https://openalex.org/W4396676821, https://openalex.org/W2016556888, https://openalex.org/W3110810129, https://openalex.org/W2007249806, https://openalex.org/W3195663446, https://openalex.org/W2032459623, https://openalex.org/W2040788846 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1038/s42004-024-01263-7 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210191625 |
| best_oa_location.source.issn | 2399-3669 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2399-3669 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Communications Chemistry |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Communications Chemistry |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s42004-024-01263-7 |
| primary_location.id | doi:10.1038/s42004-024-01263-7 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210191625 |
| primary_location.source.issn | 2399-3669 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2399-3669 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Communications Chemistry |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Communications Chemistry |
| primary_location.landing_page_url | https://doi.org/10.1038/s42004-024-01263-7 |
| publication_date | 2024-08-16 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4317831504, https://openalex.org/W2736476343, https://openalex.org/W2935701969, https://openalex.org/W4387344548, https://openalex.org/W4210394642, https://openalex.org/W4303954706, https://openalex.org/W4221063109, https://openalex.org/W2310322011, https://openalex.org/W2530302741, https://openalex.org/W3197828497, https://openalex.org/W3182488106, https://openalex.org/W4361191216, https://openalex.org/W3027174726, https://openalex.org/W4281626474, https://openalex.org/W3045203019, https://openalex.org/W3146169114, https://openalex.org/W3130648111, https://openalex.org/W2948220248, https://openalex.org/W2597078857, https://openalex.org/W3194728321, https://openalex.org/W2806672448, https://openalex.org/W2283442479, https://openalex.org/W4322769035, https://openalex.org/W2989702634, https://openalex.org/W3194342513, https://openalex.org/W4210272978, https://openalex.org/W3202723344, https://openalex.org/W4360825536, https://openalex.org/W2783474991, https://openalex.org/W2091286894, https://openalex.org/W4205345867, https://openalex.org/W4294740573, https://openalex.org/W2470671857, https://openalex.org/W2161413435, https://openalex.org/W4308439092, https://openalex.org/W4386119806, https://openalex.org/W4391573131, https://openalex.org/W2076449818, https://openalex.org/W2587625522, https://openalex.org/W4296773064, https://openalex.org/W2953320394, https://openalex.org/W2950967305, https://openalex.org/W2180229411, https://openalex.org/W2734356283, https://openalex.org/W2098167941, https://openalex.org/W2791670278, https://openalex.org/W2124026197, https://openalex.org/W2154714625, https://openalex.org/W2404280981, https://openalex.org/W2147993766, https://openalex.org/W2057477511, https://openalex.org/W2081693079, https://openalex.org/W2035687084, https://openalex.org/W2103945336, https://openalex.org/W2059013803, https://openalex.org/W1031578623, https://openalex.org/W2955168413, https://openalex.org/W3208691473 |
| referenced_works_count | 58 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5063919203 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 29 |
| citation_normalized_percentile.value | 0.80028875 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |